Results overview: Found 2 records in 0.01 seconds.
Articles, 2 records found
Articles 2 records found  
1.
40 p, 6.4 MB Roadmap on nanomedicine for the central nervous system / Ciofani, Gianni (Italian Institute of Technology) ; Campisi, Marco (Polytechnic University of Turin) ; Mattu, Clara (Polytechnic University of Turin) ; Kamm, Roger D. (Massachusetts Institute of Technology) ; Chiono, Valeria (Polytechnic University of Turin) ; Raynold, Aji Alex Moothedathu (University of Coimbra) ; Freitas, João S. (University of Coimbra) ; Redolfi Riva, Eugenio (Scuola Superiore Sant'Anna) ; Micera, Silvestro (Scuola Superiore Sant'Anna) ; Pucci, Carlotta (Italian Institute of Technology) ; Novio Vázquez, Fernando (Universitat Autònoma de Barcelona. Departament de Química) ; Lorenzo Rivera, Julia (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ruiz-Molina, Daniel (Institut Català de Nanociència i Nanotecnologia) ; Sierri, Giulia (University of Milano-Bicocca) ; Re, Francesca (University of Milano-Bicocca) ; Wunderlich, Hannah (Technical University of Munich) ; Kumari, Prachi (Technical University of Munich) ; Kozielski, Kristen L. (Technical University of Munich) ; Chami, Mounia (Institut de Pharmacologie Moléculaire et Cellulaire) ; Marino, Attilio (Italian Institute of Technology) ; Ferreira, Lino (University of Coimbra) ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
In recent years, a great deal of effort has been undertaken with regards to treatment of pathologies at the level of the central nervous system (CNS). Here, the presence of the blood-brain barrier acts as an obstacle to the delivery of potentially effective drugs and makes accessibility to, and treatment of, the CNS one of the most significant challenges in medicine. [...]
2023 - 10.1088/2515-7639/acab88
JPhys materials, Vol. 6, Issue 2 (April 2023) , art. 22501  
2.
9 p, 698.5 KB Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib : A GIMEMA, ERIC and UK CLL FORUM study / Cuneo, Antonio (St. Anna University Hospital) ; Follows, George (Cambridge University Hospitals NHS Foundation Trust (Anglaterra)) ; Rigolin, Gian Matteo (St. Anna University Hospital) ; Piciocchi, Alfonso (Italian Group for Adult Hematologic Diseases (GIMEMA)) ; Tedeschi, Alessandra (Niguarda Cancer Center) ; Trentin, Livio (University of Padua) ; Perez, Angeles Medina (Hospital Costa del Sol (Marbella)) ; Coscia, Marta (University of Turin) ; Laurenti, Luca (Policlinico A. Gemelli) ; Musuraca, Gerardo (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)) ; Farina, Lucia (Fondazione IRCCS Istituto Nazionale Tumori) ; Delgado, Alfredo Rivas (Hospital Clínic i Provincial de Barcelona) ; Orlandi, Ester Maria (Fondazione IRCCS Policlinico San Matteo) ; Galieni, Piero (Ospedale C. e G. Mazzoni) ; Mauro, Francesca Romana ("Sapienza" University) ; Visco, Carlo (San Bortolo Hospital) ; Amendola, Angela (San Carlo Hospital) ; Billio, Atto (Azienda Sanitaria dell'Alto Adige) ; Marasca, Roberto (University of Modena and Reggio Emilia) ; Chiarenza, Annalisa (Azienda Universitaria Ospedaliera Policlinico Vittorio Emanuele) ; Meneghini, Vittorio (University Hospital) ; Ilariucci, Fiorella (Arcispedale S. Maria Nuova) ; Marchetti, Monia (Cardinal Massaia Hospital) ; Molica, Stefano (Azienda Ospedaliera Pugliese Ciaccio) ; Re, Francesca (University Hospital) ; Gaidano, Gianluca (Università del Piemonte Orientale Amedeo Avogadro) ; Gonzalez, Marcos (Hospital Universitari IBSAL i CIBERONC) ; Forconi, Francesco (University Hospital National Health Service Trust) ; Ciolli, Stefania (Careggi Hospital) ; Cortelezzi, Agostino (University of Milan) ; Montillo, Marco (Niguarda Cancer Center) ; Smolej, Lukas (University Hospital) ; Schuh, Anna (Oxford University Hospitals NHS Foundation Trust) ; Eyre, Toby A. (Oxford University Hospitals NHS Foundation Trust) ; Kennedy, Ben (University Hospitals of Leicester NHS Trust) ; Bowles, Kris M. (Norwich Medical School) ; Vignetti, Marco (Italian Group for Adult Hematologic Diseases (GIMEMA)) ; De La Serna, Javier (Hospital 12 de Octubre (Madrid)) ; Moreno, Carol (Institut d'Investigació Biomèdica Sant Pau) ; Foà, Robin ("Sapienza" University) ; Ghia, Paolo (IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University) ; Universitat Autònoma de Barcelona
We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salvage regimen in chronic lymphocytic leukemia (CLL). In an intention-to-treat analysis including 237 patients, the median progression-free survival (PFS) was 25 months. [...]
2018 - 10.3324/haematol.2018.189837
Haematologica, Vol. 103 Núm. 7 (march 2018) , p. 1209-1217  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.